AASLD 2010 - Pre-Register for the November 2, 2010 Live Internet Symposium

[Guest guest]

Having trouble viewing this email? Click here

November 2, 2010

at 11:00 AM EDT (15:00 GMT)

A Live Continuing Medical Education Program

This 1.5 hour live internet symposium will review and discuss the key studies on

chronic hepatitis C management and treatment presented at AASLD. The symposium

will feature 4 well-known and recognized thought leaders in the HCV field, with

3 serving as presenting faculty/discussants and 1 as program moderator. This

activity has been designed to meet the educational needs of physicians involved

in the care of patients with chronic hepatitis C infection.

Supported by an educational grant from Merck & Co., Inc.

Course Director and Moderator

Mark Sulkowski, MD

Associate Professor of Medicine and Medical Director,

Viral Hepatitis Center,

s Hopkins University School of Medicine

Baltimore, land

Faculty

Yves Benhamou, MD

Associate professor of Hepatology,

Service d’Hépato-Gastro-Entérologie

Groupe Hospitalier Pitié-Salpêtrière

Paris, France

Fred Poordad, MD

Chief, Hepatology

Cedars-Sinai Medical Center

Associate Professor of Medicine

Geffen School of Medicine at UCLA

Los Angeles, California

K. Rajender Reddy, MD

Professor of Medicine

Professor of Medicine in Surgery

Director of Hepatology

Medical Director of Liver Transplantation

University of Pennsylvania School of Medicine

Philadelphia, Pennsylvania

Learning Objectives:

After completing this activity, the participant should be able to:

1.

Implement appropriate monitoring and testing;

2.

Explain and use, in a clinical setting, the key new studies on chronic hepatitis

C management and treatment presented at the 61st AASLD;

3.

Apply treatment paradigms for chronic hepatitis C;

4.

Discuss with patients the studies and data on newer therapies for chronic

hepatitis C presented at the 61st AASLD;

5.

Apply information on newer therapies in therapeutic discussions.

Target Audience:

This activity has been designed to meet the educational needs of physicians

involved in the care of patients with chronic HCV infection.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential

Areas and policies of the Accreditation Council for Continuing Medical Education

(ACCME) through the joint sponsorship of Postgraduate Institute for Medicine PIM

and ViralEd, LLC. PIM is accredited by the ACCME to provide continuing medical

education for physicians..

Credit Designation Statement:

PIM designates this educational activity for a maximum of 1.5 AMA PRA Category 1

Credits™. Physicians should only claim credit commensurate with the extent of

their participation in the activity.

Disclosure of Conflicts of Interest:

PIM requires instructors, planners, managers and other individuals who are in a

position to control the content of this activity to disclose any real or

apparent conflict of interest they may have as related to the content of this

activity. All identified conflicts of interest are thoroughly vetted by PIM for

fair balance, scientific objectivity of studies mentioned in the materials or

used as the basis for content, and appropriateness of patient care

recommendations.

This coverage is not sanctioned by the conference organizers and

is not an official part of the conference proceedings.

Forward email

This email was sent to shereemartin@... by newsletter@....

Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy

Policy.

Email Marketing by

HIVandHepatitis.com | P.O. Box 2010 | San Francisco | CA | 94114